U.S. Endoscopes Market (By Product: Flexible Endoscopes, Capsule Endoscopes, Robot Assisted Endoscopes, Rigid Endoscopes, Disposable Endoscopes; By Application: Arthroscopy, Urology Endoscopy, Laparoscopy, Gastrointestinal (GI) Endoscopy, Bronchoscopy, Mediastinoscopy, Gynecology Endoscopy, Otoscopy, Laryngoscopy, Others; By End-Use: Ambulatory Surgery Centers, Hospitals, Others) - Regional Outlook and Forecast 2024 to 2033
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: U.S. Endoscopes Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. U.S. Endoscopes Market Revenue and Volume, by Product, 2024-2033
8.1.1 Flexible Endoscopes
8.1.1.1. Market Revenue and Volume Forecast (2021-2033)
8.1.2. Capsule Endoscopes
8.1.2.1. Market Revenue and Volume Forecast (2021-2033)
8.1.3. Robot Assisted Endoscopes
8.1.3.1. Market Revenue and Volume Forecast (2021-2033)
8.1.4. Rigid Endoscopes
8.1.4.1. Market Revenue and Volume Forecast (2021-2033)
8.1.5. Disposable Endoscopes
8.1.5.1. Market Revenue and Volume Forecast (2021-2033)
9.1. U.S. Endoscopes Market Revenue and Volume, by Application, 2024-2033
9.1.1. Arthroscopy
9.1.1.1. Market Revenue and Volume Forecast (2021-2033)
9.1.2. Urology Endoscopy
9.1.2.1. Market Revenue and Volume Forecast (2021-2033)
9.1.3. Laparoscopy
9.1.3.1. Market Revenue and Volume Forecast (2021-2033)
9.1.4. Gastrointestinal (GI) Endoscopy
9.1.4.1. Market Revenue and Volume Forecast (2021-2033)
9.1.5. Bronchoscopy
9.1.5.1. Market Revenue and Volume Forecast (2021-2033)
9.1.6. Mediastinoscopy
9.1.6.1. Market Revenue and Volume Forecast (2021-2033)
9.1.7. Gynecology Endoscopy
9.1.7.1. Market Revenue and Volume Forecast (2021-2033)
9.1.8. Otoscopy
9.1.8.1. Market Revenue and Volume Forecast (2021-2033)
9.1.9. Laryngoscopy
9.1.9.1. Market Revenue and Volume Forecast (2021-2033)
9.1.10. Others
9.1.10.1. Market Revenue and Volume Forecast (2021-2033)
10.1. U.S. Endoscopes Market Revenue and Volume, by End-Use, 2024-2033
10.1.1. Ambulatory Surgery Centers
10.1.1.1. Market Revenue and Volume Forecast (2021-2033)
10.1.2. Hospitals
10.1.2.1. Market Revenue and Volume Forecast (2021-2033)
10.1.3. Others
10.1.3.1. Market Revenue and Volume Forecast (2021-2033)
11.1. U.S.
11.1.1. Market Revenue and Volume Forecast, by Product (2021-2033)
11.1.2. Market Revenue and Volume Forecast, by Application (2021-2033)
11.1.3. Market Revenue and Volume Forecast, by End-Use (2021-2033)
12.1. Olympus Corporation
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Stryker Corporation
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Ethicon Endo-Surgery, Inc
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Boston Scientific
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Arthrex, Inc.
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. ConMed
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Medtronic
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Johnson & Johnson
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Cook Medical
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Richard Wolf GmbH
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
14.1. About Us
14.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client